Stock Track | Harrow Health Plunges 13.91% After-Hours on Q3 Earnings Miss

Stock Track11-11

Shares of Harrow Health Inc (HROW) tumbled 13.91% in after-hours trading on Monday following the release of its third-quarter 2025 financial results, which fell short of analysts' expectations.

The specialty pharmaceutical company reported an adjusted earnings per share (EPS) of $(0.12), significantly missing the estimated $0.26. Revenue for the quarter came in at $71.638 million, also falling short of the anticipated $73.705 million. This double miss on both top and bottom lines appears to have spooked investors, leading to the sharp decline in share price.

Despite the disappointing headline numbers, Harrow did report some positive metrics. The company's core gross margin stood at a healthy 81%, while the overall gross margin was 75%. Additionally, Harrow's core EPS was reported at $0.33. However, these figures were not enough to offset the impact of the missed estimates, as evidenced by the stock's significant after-hours drop.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1161618879?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-11 05:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161618879","market":"nz","top_or_hot":-1,"title":"Stock Track | Harrow Health Plunges 13.91% After-Hours on Q3 Earnings Miss","media":"Stock Track","content":"<p>Shares of Harrow Health Inc (HROW) tumbled 13.91% in after-hours trading on Monday following the release of its third-quarter 2025 financial results, which fell short of analysts' expectations.</p>\n\n<p>The specialty pharmaceutical company reported an adjusted earnings per share (EPS) of $(0.12), significantly missing the estimated $0.26. Revenue for the quarter came in at $71.638 million, also falling short of the anticipated $73.705 million. This double miss on both top and bottom lines appears to have spooked investors, leading to the sharp decline in share price.</p>\n\n<p>Despite the disappointing headline numbers, Harrow did report some positive metrics. The company's core gross margin stood at a healthy 81%, while the overall gross margin was 75%. Additionally, Harrow's core EPS was reported at $0.33. However, these figures were not enough to offset the impact of the missed estimates, as evidenced by the stock's significant after-hours drop.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Harrow Health Plunges 13.91% After-Hours on Q3 Earnings Miss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Harrow Health Plunges 13.91% After-Hours on Q3 Earnings Miss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-11 05:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Harrow Health Inc (HROW) tumbled 13.91% in after-hours trading on Monday following the release of its third-quarter 2025 financial results, which fell short of analysts' expectations.</p>\n\n<p>The specialty pharmaceutical company reported an adjusted earnings per share (EPS) of $(0.12), significantly missing the estimated $0.26. Revenue for the quarter came in at $71.638 million, also falling short of the anticipated $73.705 million. This double miss on both top and bottom lines appears to have spooked investors, leading to the sharp decline in share price.</p>\n\n<p>Despite the disappointing headline numbers, Harrow did report some positive metrics. The company's core gross margin stood at a healthy 81%, while the overall gross margin was 75%. Additionally, Harrow's core EPS was reported at $0.33. However, these figures were not enough to offset the impact of the missed estimates, as evidenced by the stock's significant after-hours drop.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HROW","symbol_name":"Harrow Health Inc","start_time":0,"source_url":"","article_id":"1161618879","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161618879","pubTimestamp":1762810340,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Harrow Health Inc (HROW) tumbled 13.91% in after-hours trading on Monday following the release of its third-quarter 2025 financial results, which fell short of analysts' expectations.  The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HROW":"Harrow Health Inc"},"translate_title":"个股追踪|哈罗健康第三季度盈利未达预期盘后暴跌13.91%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HROW":1},"content_text":"Shares of Harrow Health Inc (HROW) tumbled 13.91% in after-hours trading on Monday following the release of its third-quarter 2025 financial results, which fell short of analysts' expectations.\nThe specialty pharmaceutical company reported an adjusted earnings per share (EPS) of $(0.12), significantly missing the estimated $0.26. Revenue for the quarter came in at $71.638 million, also falling short of the anticipated $73.705 million. This double miss on both top and bottom lines appears to have spooked investors, leading to the sharp decline in share price.\nDespite the disappointing headline numbers, Harrow did report some positive metrics. The company's core gross margin stood at a healthy 81%, while the overall gross margin was 75%. Additionally, Harrow's core EPS was reported at $0.33. However, these figures were not enough to offset the impact of the missed estimates, as evidenced by the stock's significant after-hours drop.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1161618879","isCrawlerRequest":true}